TSTimur V. Schäfer

Timur V. Schäfer

*This is an algorithmically generated author record based on publicly available information.

Timur V. Schäfer has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • JuYu Ivnitsky

    Golikov Research Center of Toxicology

    4 shared publications
  • Ju. Ju. Ivnitsky

    Golikov Research Center of Toxicology, Federal Medico-Biological Agency of Russia, Saint Petersburg, Russia

    3 shared publications
  • O. A. Vakunenkova

    Golikov Research Center of Toxicology, Federal Medico-Biological Agency of Russia, Saint Petersburg, Russia

    3 shared publications
  • V. L. Rejniuk

    Golikov Research Clinical Center of Toxicology, Federal Medical Biological Agency, St. Petersburg, Russia

    2 shared publications
  • Vladimir L. Rejniuk

    Laboratory of Origin, Institute of Toxicology, Federal Medical Biological Agency, 1, ul. Bekhtereva, St. Petersburg, 192019, Russia

    2 shared publications
  • A. I. Golovko

    Golikov Scientific and Clinical Center of Toxicology, St. Petersburg, Russia

    1 shared publication

Latest Publications

  • Open Access

    Experimental Assessment of Tourniquet Times Effect on Course and Outcome of Combined Radiation and Mechanical Injury

    by Artyom M. Nosov, Anatoly V. Zhabin, Alexey B. Seleznyov, Igor M. Samokhvalov, Timur V. Schäfer, Vladislav S. Kudryashov, Nikita V. Romanov, Селезнёв Алексей Борисович

    BACKGROUND: Acute uncompensated blood loss due to continuous external bleeding is a common cause of death among military personnel wounded in combat. Tourniquets have been recognized as the primary method to temporarily control bleeding. Successful injury management is predicated on the adherence to recommended guidelines for tourniquet application and replacement with blood flow restoration. For combined radiation injury, shorter tourniquet times are associated with extended radiation component. AIM: This study aimed to establish the correlation between hemostatic tourniquet times and the course and outcome of moderate combined radiation and mechanical injuries in an experimental setting. METHODS: The study included 60 male Soviet Chinchilla rabbits with an average body weight of 2.5–3 kg. The animals were exposed to a single dose (6 Gy) of uniform γ-radiation and had mechanical damage to tissues and a large artery of the limb with hemoexfusion of 30% of the circulating blood volume. The tourniquet time was 15, 45, or 120 minutes. A The mechanical component of the injury was initiated 1 hour post-exposure. RESULTS: In the combined radiation and mechanical injury model, prolonged tourniquet time was associated with a more adverse outcome. Specifically, 8 (80%) rabbits survived after a 15-minute tourniquet application, with 30% survival (3 rabbits) observed at 45 minutes and 20% (2 rabbits) at 120 minutes. Tourniquet time did not affect the onset of radiation component of the injury. Comparison of the groups with the reproduced model of the combined injury and isolated injury showed that the radiation component did not affect the survival of animals with combined radiation and mechanical injuries. CONCLUSION: Prolonging tourniquet time is crucial in increasing animal mortality, with this effect being independent of the radiation component (in the specified experimental model). If we extrapolate the experimental data to humans, it can be concluded that individuals with combined radiation injury and those who suffer from isolated injury should be medically evacuated in a way that minimizes tourniquet time. Furthermore, it is critical to consider medical and tactical situations to ensure that the most effective methods for bleeding control are used.

  • Open Access

    Dynamics of the content of immunoglobulin G to severe acute respiratory syndrome-2 in convalescents who have had a new coronavirus infection

    by Ivan V. Fateev, Timur V. Schöfer, Sergey V. Chepur, Evgeniy V. Ivchenko, Timur I. Minnullin, Alla A. Shubina, Alexander V. Stepanov

    The study investigated the dynamics of class G immunoglobulins to severe acute respiratory syndrome-2 coronavirus in the blood serum of convalescents who had a new coronavirus infection for 6 months after the polymerase chain reaction conversion. Among the most common symptoms, 30 (73.8%) convalescents had an increase in body temperature to 38C, 32 (83.3%) had asthenia, 21 (59.5%) had cough, 29 (73.8%) had perversion or loss of sense of smell, pain, and throat discomfort. The duration of symptoms varied from 34 days to 34 weeks. Within a month after the end of the acute disease period, 8 (20%) patients had a decrease in working capacity, 13 (33%) had difficulty breathing, 9 (22%) had a cough, and 4 (10%) had pain and sore throat. During severe acute respiratory syndrome 2 infection, the virus activates the innate and adaptive immunity, resulting in the formation of specific class G immunoglobulins to the pathogens. After leveling the clinical manifestations, class G immunoglobulins were detected in the majority of convalescents (79%90%) during the first 6 months, starting from day 14 from disease onset with a predominantly high ( 10 conl. units) positivity coefficient. Moreover, this pattern occurred in both men and women; however, in some studies, the levels of the positivity coefficient of class G immunoglobulins began to decrease by the fifth month of follow-up and sometimes at an earlier time (2 months). Perhaps, this is due to the different functional activities of the immune system of each convalescent, infecting dose of the pathogen, and peculiarities of its interaction with the macroorganism and its immune system. Nevertheless, the class G immunoglobulins identified in the study do not yet indicate the probability of reinfection of convalescents with the same pathogen. The protective titer of antibodies has yet to be investigated further.

  • Self-Destructive Behavior among Predictors of Cancer Incidence

    by T. V. Schäfer, O. A. Vakunenkova, K. V. Firsov, Ju. Ju. Ivnitsky

    Human cancer is typical for the elderly. Therefore, the genetic predisposition to it is not the subject of negative intraspecific selection. This creates a risk of accumulation of a gene pool of disorders (mutations, unstable genomes), for which an increased risk of malignant neoplasms is only one of the phenotypic manifestations in the population. This danger is counteracted by non-tumor pathology, which reduces the likelihood of an individual participating in reproduction. Inherited together with an increased predisposition to malignant neoplasms, it naturally precedes them and often manifests in behavioral disorders. A self-destructive behavior is one form of behavioral disorder. The article considers the hypothesis of smoking and overeating as patterns of species-specific self-destructive behavior, the predisposition to which is inherited together with an increased risk of malignant neoplasms. Approaches to testing the hypothesis by applying a system of incentives that block self-destructive behavior are proposed.


  • Analysis and Evaluation of Modern Approaches to Development of Medical Drugs Using Micro- and Nanotechnologies

    by Evgeniy V. Raguzin, Mikhail A. Yudin, Daniil D. Glushenko, Nikolay G. Vengerovich, Ol’gA G. Raguzina, Tat’yAna B. Pechurina, Timur V. Shefer, Igor’ M. Ivanov, Юдин Михаил Анатольевич

    INTRODUCTION: TDespite the achievements of the modern medicine, use of some medical drugs (MDs) is associated with both the absence of a significant therapeutic effect due to peculiarities of the physico-chemical interaction in the internal environment of an organism, and with the adverse effect on organs and tissues. The advanced technologies of creation of micro- and nanoparticles will permit to improve pharmacokinetics and pharmacodynamics of the drug, its bioavailability and solubility, the ability of crossing blood-brain barriers, and to reduce undesirable systemic effects. MDs using micro- and nanoparticles, have a targeted effect on the focus of pathological lesion. An important additional advantage is a possibility of using micro- and nanoparticles in development of long-acting MDs. The main active substances immobilized to micro- and nanoparticles, open up new prospects for effective treatment of different pathological conditions (neoplasms, diseases of cardiovascular and central nervous system, inflammatory processes, wounds), and for realization of new imaging capabilities in foci of a pathological process, which is especially important in diagnostic procedures. CONCLUSION: The article presents a summary of the ideas of methods of micro- and nanoencapsulation, and assessments of the prospects for the development of drugs for the correction of pathological conditions using innovative technologies.


  • Open Access

    Secondary Dysfunction of the Intestinal Barrier in the Pathogenesis of Complications of Acute Poisoning

    by Ju. Ju. Ivnitsky, T. V. Schäfer, V. L. Rejniuk, O. A. Vakunenkova

    The last decade has been marked by an exponential increase in the number of publications on the physiological role of the normal human gut microbiota. The idea of a symbiotic relationship between the human organism and normal microbiota of its gastrointestinal tract has been firmly established as an integral part of the current biomedical paradigm. However, the type of this symbiosis varies from mutualism to parasitism and depends on the functional state of the host organism. Damage caused to the organism by external agents can lead to the emergence of conditionally pathogenic properties in the normal gut microbiota, mediated by humoral factors and affecting the outcome of exogenous exposure. Among the substances produced by symbiotic microbiota, there are an indefinite number of compounds with systemic toxicity. Some occur in the intestinal chyme in potentially lethal amounts in the case they enter the bloodstream quickly. The quick entry of potential toxicants is prevented by the intestinal barrier (IB), a set of structural elements separating the intestinal chyme from the blood. Hypothetically, severe damage to the IB caused by exogenous toxicants can trigger a leakage and subsequent systemic redistribution of toxic substances of bacterial origin. Until recently, the impact of such a redistribution on the outcome of acute exogenous poisoning remained outside the view of toxicology. The present review addresses causal relationships between the secondary dysfunction of the IB and complications of acute poisoning. We characterize acute systemic toxicity of such waste products of the normal gut microflora as ammonia and endotoxins, and demonstrate their involvement in the formation of such complications of acute poisoning as shock, sepsis, cerebral insufficiency and secondary lung injuries. The principles of assessing the functional state of the IB and the approaches to its protection in acute poisoning are briefly considered.


  • Gut Barrier in Critical States of the Body

    by T. V. Schäfer, O. A. Vakunenkova, Ju. Ju. Ivnitsky, A. I. Golovko

    The intestinal barrier (IB) is a system of diffusion barriers separating the intestinal chyme and blood. The aim of the review is to identify the role of IB dysfunction in the formation of critical states of the body and to substantiate ways to prevent these states. Toxic substances produced by normal intestinal microflora are characterized. The involvement of endotoxin and ammonia in the pathogenesis of sepsis, acute circulatory disorders, secondary acute pulmonary lesions, and acute cerebral insufficiency is shown. Approaches to protect the IB in critical states of the body are proposed.


  • Endogenous humoral determinants of vascular endothelial dysfunction as triggers of acute poisoning complications

    by Jury Ju. Ivnitsky, Timur V. Schäfer, Vladimir L. Rejniuk, Alexandr I. Golovko

    The vascular endothelium is not only the semipermeable membrane that separates tissue from blood but also an organ that regulates inflammation, vascular tone, blood clotting, angiogenesis and synthesis of connective tissue proteins. It is susceptible to the direct cytotoxic action of numerous xenobiotics and to the acute hypoxia that accompanies acute poisoning. This damage is superimposed on the preformed state of the vascular endothelium, which, in turn, depends on many humoral factors. The probability that an exogenous toxicant will cause life‐threatening dysfunction of the vascular endothelium, thereby complicating the course of acute poisoning, increases with an increase in the content of endogenous substances in the blood that disrupt endothelial function. These include ammonia, bacterial endotoxin, indoxyl sulfate,para‐cresyl sulfate, trimethylamineN‐oxide, asymmetric dimethylarginine, glucose, homocysteine, low‐density and very‐low‐density lipoproteins, free fatty acids and products of intravascular haemolysis. Some other endogenous substances (albumin, haptoglobin, haemopexin, biliverdin, bilirubin, tetrahydrobiopterin) or food‐derived compounds (ascorbic acid, rutin, omega‐3 polyunsaturated fatty acids, etc.) reduce the risk of lethal vascular endothelial dysfunction. The individual variability of the content of these substances in the blood contributes to the stochasticity of the complications of acute poisoning and is a promising target for the risk reduction measures. Another feasible option may be the repositioning of drugs that affect the function of the vascular endothelium while being currently used for other indications.


  • Permeability of Intestinal and Blood—Tissue Barriers in Rats for Evans Blue Dye under Conditions of Acute Intoxication with Cyclophosphamide

    by T. V. Schäfer, Ju. Ju. Ivnitsky, V. L. Rejniuk

    Myeloablative therapy was modeled by administration of cyclophosphamide to rats in a dose of 2.1 LD50 for 14 days. Under these conditions, increased accumulation of Evans blue dye given by gavage was observed in the blood, brain, lung, liver, kidney, and ileum (by 34, 1.6, 149, 46, 30, and 6.2 times, respectively). After intravenous injection of the dye, its accumulation was increased only in the lung and ileum. Thus, simulation of myeloablation cytostatic therapy by cyclophosphamide injection to rats is associated with impairment of the intestinal and lung—blood barriers. These alterations predispose to penetration of biologically active substances from the small intestine, gastrointestinal chyme, and lungs to the blood, thus contributing to the development of the early toxic effects of cyclophosphamide.


  • Open Access

    Promotion of the Toxic Action of Cyclophosphamide by Digestive Tract Luminal Ammonia in Rats

    by Jury Ju. Ivnitsky, Timur V. Schäfer, Vladimir L. Rejniuk

    To estimate the influence of the digestive tract luminal ammonia pool on acute toxic effects of cyclophosphamide, the dynamics of blood ammonia, glutamine and urea level, symptoms of toxic action and the survival time have been studied in rats, intraperitoneally treated with cyclophosphamide, at the background of the gavage with non-lethal dose of ammonium acetate (12 mmol/kg, i.e., 0.35 LD50). Ammonium acetate enhanced the hyperammonaemic action of cyclophosphamide while promoting its lethal action: the mean survival time decreased 1.5, 2.1, 2.8, or 6.1 times at the background of cyclophosphamide i/p doses 200, 600, 1000, or 1400 mg/kg, respectively. Animals exposed to the combination of toxicants, manifested symptoms which were characteristic of the effect of lethal doses of ammonia salts. These data provide the evidence of the detrimental role of gastrointestinal luminal ammonia in the acute high-dose cyclophosphamide toxicity.


  • Cyclophosphamide-induced leakage of gastrointestinal ammonia into the common bloodstream in rats

    by Timur V. Schäfer, Jury Ju. Ivnitsky, Vladimir L. Rejniuk

    The kinetics of ammonia of gastrointestinal origin has been studied in rats in hematopoietic or neurovascular forms of acute lethal cyclophosphamide intoxication. Portal and caval blood ammonia, glutamine and urea, and blood markers of cytolysis were determined, and transperitoneal ammonia and glutamine fluxes were estimated after the single high-dose cyclophosphamide intraperitoneal (i.p.) administration. Within 3 hours after the administration of cyclophosphamide (200, 600, or 1,000 mg/kg), the portal ammonia level increased 1.4, 1.8, and 2.5 times, respectively; the ammonia level in v. cava caud. caudally of vv. renales inflow increased 1.5, 2.1, and 3.3 times, and cranially of vv. hepaticae, 1.8, 2.7, and 4.2 times, respectively; glutamine:ammonia and urea:ammonia ratios decreased. The rate of ammonia and glutamine accumulation in saline solution injected i.p. exceeded that in control rats dose dependently. At 18 hours after the administration of cyclophosphamide, the increased blood ammonia, glutamine and urea, and glutamine:ammonia ratio persisted. Therefore, in the rat, the high-dose i.p. administration of cyclophosphamide induces the early hyperammonemia, resulting from the enhanced transperitoneal diffusion of gastrointestinal ammonia into the blood, combined with the restriction of glutamine and urea synthesis. These alterations may contribute to neurological complications of myelosuppressive therapeutic regimens of cyclophosphamide administration.